Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022 Read more about Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022
Bone Therapeutics reports half year 2022 results Read more about Bone Therapeutics reports half year 2022 results
Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA Read more about Bone Therapeutics: Transparency notification received from S.R.I.W. SA and Sofipôle SA
Bone Therapeutics: Information on the total number of voting rights and shares (May 2020) Read more about Bone Therapeutics: Information on the total number of voting rights and shares (May 2020)
Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study Read more about Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study
Bone Therapeutics to host Annual Ordinary General Meeting on 10 June 2020 Read more about Bone Therapeutics to host Annual Ordinary General Meeting on 10 June 2020
Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15 million committed, providing runway into Q2 2021 Read more about Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15 million committed, providing runway into Q2 2021
Bone Therapeutics Provides First Quarter 2020 Business Update Read more about Bone Therapeutics Provides First Quarter 2020 Business Update
Bone Therapeutics secures EUR 11.0 million financing Read more about Bone Therapeutics secures EUR 11.0 million financing
Bone Therapeutics: Information on the total number of voting rights and shares (March 2020) Read more about Bone Therapeutics: Information on the total number of voting rights and shares (March 2020)
